Moreover, RUNX2 downstream AKT/β-catenin/Survivin (also known as BIRC5) signaling pathway was suppressed, leading to deregulation of bone formation-related TCF and LEF transcription factors and consequently tumor suppression [52,69]. Here, RUNX2 is linked to neoplasm.